Skip to content
PubMed This is a summary of 11 peer-reviewed journal articles Updated
Immunology

Protecting Your Kidney Health and Managing Autoimmune Risks

At a Glance

Complete C3 deficiency can be associated with kidney inflammation, but kidney disease is not inevitable. Regular urine tests, blood pressure checks, and kidney blood tests can detect silent changes early; dark urine, swelling, reduced urine, or severe symptoms need prompt medical attention.

While the most immediate concern in complete C3 deficiency is preventing infections, your medical team will also focus on a second major area: kidney health. Because the C3 protein is the “central hub” of the immune system, its absence can sometimes cause the body to have trouble clearing out immune debris (immune complexes). This can lead to complement-mediated inflammation in the small filters of the kidney, known as the glomeruli [1][2].

It is important to remember that these complications are reported complications, but their frequency is uncertain given the small number of cases. Complete C3 deficiency does not automatically cause glomerulonephritis, and progression to kidney failure is not expected for every patient [3][4]. However, because of the risk, lifelong monitoring by a specialist is standard care.

Understanding Kidney Complications

The primary kidney concern in C3 deficiency is glomerulonephritis, a term for inflammation of the kidney’s filtering units. If these filters become inflamed, they cannot effectively clean the blood, which can lead to long-term damage [1][4]. A biopsy may sometimes be needed to accurately classify the type of kidney injury.

Several specific types of kidney issues have been reported in patients with this condition:

  • Membranoproliferative Glomerulonephritis (MPGN): One of the reported kidney patterns seen in C3 deficiency. It involves a thickening and “clogging” of the kidney filters [1][3].
  • Crescentic Glomerulonephritis: A more severe and rapid form of inflammation that can lead to significant kidney scarring [4].
  • Hemolytic Uremic Syndrome (HUS): A rare clinical syndrome involving microangiopathic hemolytic anemia (the destruction of red blood cells), thrombocytopenia (low platelets), and acute kidney injury [5][1]. Suspected HUS requires urgent medical evaluation.

In some documented cases, if these conditions are not managed, they can progress to end-stage renal disease (ESRD), where the kidneys no longer function well enough to sustain life without dialysis or a transplant [4][2].

Monitoring for Changes

Kidney issues often do not “feel” like anything in the early stages. You won’t necessarily have pain in your back or side. Instead, doctors look for “silent” markers in the urine and blood [6][7]. Your nephrologist will determine an individualized follow-up framework.

  • Hematuria: The presence of blood in the urine. While it may sometimes be visible (looking like tea or cola), it is often “microscopic,” meaning it can only be seen under a microscope during a routine lab test [6].
  • Proteinuria: Finding protein in the urine, which can sometimes make the urine look foamy or bubbly. This is a sign that the kidney filters are “leaky.” Note that transient blood or protein can occur after an illness and may simply require repeat testing [6][7].
  • Hypertension: High blood pressure is both a symptom and a cause of kidney damage. Regular blood pressure checks are a vital part of your care [1][6].
  • Creatinine and eGFR: These are blood tests that measure how well your kidneys are filtering waste from your body [6][7].

Urgent Kidney Warning Signs

While routine tests catch silent markers, you should contact your care team promptly if you notice any of the following signs:

  • Dark, tea-colored, or bloody urine.
  • New, unexplained swelling (edema), especially in the face, hands, or legs.
  • Significantly reduced urine output.
  • Severe headaches or repeated high blood pressure readings.
  • Extreme pallor (paleness) or unusual bruising.

C3 vs. Other Complement Deficiencies

You may read about other complement deficiencies (like C1, C2, or C4) that are very strongly linked to Systemic Lupus Erythematosus (SLE), or “lupus.” In those conditions, the primary threat is often the body attacking its own tissues, causing joint pain and rashes [1][8][9].

In C3 deficiency, the situation is slightly different:

  • Infection and Kidney Disease are the “dominant” symptoms [1][3].
  • While some patients with C3 deficiency do develop lupus-like symptoms (such as skin lesions or joint pain), it is less common than in other complement disorders [1][10].
  • The kidney issues in C3 deficiency are often driven more by the body’s inability to manage immune complexes than by the “classic” lupus pathway [1][11].

A Proactive Approach

Because kidney issues can appear in childhood or even first emerge in adulthood, specialists recommend a consistent monitoring schedule [4][2]. Catching inflammation early allows doctors to use medications that can protect the kidneys and prevent long-term damage.

Common questions in this guide

What kidney problems can complete C3 deficiency cause?
Complete C3 deficiency has been associated with glomerulonephritis, including membranoproliferative and crescentic forms, as well as the less common hemolytic uremic syndrome. These problems can impair kidney filtering and may progress to kidney failure in some cases, but kidney disease is not inevitable.
How do doctors monitor the kidneys in C3 deficiency?
Monitoring may include urine tests for blood and protein, regular blood pressure checks, and blood tests such as creatinine and eGFR. Because early kidney changes may cause no noticeable symptoms, a nephrologist should set an individualized follow-up schedule.
Which symptoms need prompt medical attention?
Contact your care team promptly for dark or bloody urine, new swelling, much less urine, severe headaches, repeated high blood pressure readings, unusual paleness, or unexplained bruising. Suspected hemolytic uremic syndrome, which can involve anemia, low platelets, and acute kidney injury, requires urgent medical evaluation.
Does C3 deficiency cause lupus or other autoimmune symptoms?
Some people with C3 deficiency develop lupus-like symptoms such as joint pain or skin lesions, but these are less common than in some other complement deficiencies. Kidney problems in C3 deficiency are often related to difficulty clearing immune complexes rather than the classic lupus pathway.
Can C3 deficiency lead to kidney failure?
Progression to end-stage kidney disease has been reported when serious kidney complications are not managed, but it is not expected for every person with C3 deficiency. Lifelong monitoring can help identify inflammation or declining kidney function early.
When might a kidney biopsy be needed?
A kidney biopsy may be needed when doctors must identify and classify the type of kidney injury, especially if tests suggest glomerulonephritis. The result can help the medical team understand the kidney problem and plan care.

Get notified when new evidence is published on Complement component 3 deficiency.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (11)
  1. 1

    The yin and the yang of early classical pathway complement disorders.

    Sullivan KE

    Clinical and experimental immunology 2022; (209(2)):151-160 doi:10.1093/cei/uxac056.

    PMID: 35648651
  2. 2

    Combined liver-kidney transplantation for rare diseases.

    Knotek M, Novak R, Jaklin-Kekez A, Mrzljak A

    World journal of hepatology 2020; (12(10)):722-737 doi:10.4254/wjh.v12.i10.722.

    PMID: 33200012
  3. 3

    Case Report: A novel homozygous splice-site variant in the C3 gene causing complete complement C3 deficiency in two unrelated Moroccan patients.

    Oujane C, Hbibi M, Benhsaien I, et al.

    Frontiers in immunology 2026; (17()):1860941 doi:10.3389/fimmu.2026.1860941.

    PMID: 42445183
  4. 4

    Successful simultaneous liver-kidney transplantation for renal failure associated with hereditary complement C3 deficiency.

    Nayagam JS, McGrath S, Montasser M, et al.

    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2020; (20(8)):2260-2263 doi:10.1111/ajt.15785.

    PMID: 31970896
  5. 5

    Case Report: C3 deficiency in two siblings.

    Bernacchia A, Ginaca A, Rotondo S, et al.

    Frontiers in pediatrics 2024; (12()):1424380 doi:10.3389/fped.2024.1424380.

    PMID: 39114852
  6. 6

    Membranoproliferative glomerulonephritis and C3 glomerulopathy in children: change in treatment modality? A report of a case series.

    Spartà G, Gaspert A, Neuhaus TJ, et al.

    Clinical kidney journal 2018; (11(4)):479-490 doi:10.1093/ckj/sfy006.

    PMID: 30094012
  7. 7

    Long-term follow-up including extensive complement analysis of a pediatric C3 glomerulopathy cohort.

    Michels MAHM, Wijnsma KL, Kurvers RAJ, et al.

    Pediatric nephrology (Berlin, Germany) 2022; (37(3)):601-612 doi:10.1007/s00467-021-05221-6.

    PMID: 34476601
  8. 8

    Homozygous C1qA Deficiency Presenting as Early-Onset Systemic Lupus Erythematosus: A Case Report With a Literature Review.

    Mottaghipisheh H, Jahromi AM, Mirzaei F, et al.

    Case reports in immunology 2026; (2026()):4667037 doi:10.1155/crii/4667037.

    PMID: 42147803
  9. 9

    Clinical and population genetic insights into primary complement component 2 (C2) deficiency: A founder variant in Ashkenazi Jews.

    Shamriz O, Molho-Pessach V, Benshushan S, et al.

    Clinical immunology (Orlando, Fla.) 2026; (287()):110758 doi:10.1016/j.clim.2026.110758.

    PMID: 42521109
  10. 10

    Lupus manifestations in children with primary immunodeficiency diseases: Comprehensive phenotypic and genetic features and outcome.

    Al-Mayouf SM, Alreefi HA, Alsinan TA, et al.

    Modern rheumatology 2021; (31(6)):1171-1178 doi:10.1080/14397595.2021.1886627.

    PMID: 33563058
  11. 11

    C1q restrains autoimmunity and viral infection by regulating CD8+ T cell metabolism.

    Ling GS, Crawford G, Buang N, et al.

    Science (New York, N.Y.) 2018; (360(6388)):558-563 doi:10.1126/science.aao4555.

    PMID: 29724957

This page is for informational purposes only and does not constitute medical advice. It explains kidney monitoring and autoimmune risks in complete C3 deficiency; your immunologist or nephrologist should guide care for your specific situation.